The rapid kinetics of optimal treatment with subcutaneous methotrexate in early inflammatory arthritis: an observational study

BACKGROUND: Methotrexate (MTX) is standard treatment for RA. Absorption is better in subcutaneous MTX (scMTX), which may impact speed of onset. In RA, earlier time to remission improves long-term results. Our objectives were to determine rapidity of response of subcutaneous methotrexate in early rhe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Musculoskelet Disord
Main Authors: O’Connor, Anna, Thorne, Carter, Kang, Hyeon, Tin, Diane, Pope, Janet E.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4997744/
https://ncbi.nlm.nih.gov/pubmed/27558249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-016-1213-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares